Brief: Xvivo Perfusion's CEO Dag Andersson Passes Away
Sept 27 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* XVIVO PERFUSION'S CEO DAG ANDERSSON HAS PASSED AWAY
* BOARD DECIDED THAT CHRISTOFFER ROSENBLAD, CURRENTLY VICE
PRESIDENT AT XVIVO, WILL TAKE OVER AS ACTING CEO UNTIL A
SUCCESSOR HAS BEEN APPOINTED
Source text for Eikon: ID:nMFN16qgqF
Further company coverage: XVIVO.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength